您的 投票 計票！ 在會議上進行虛擬投票* 2022年11月29日 東部時間上午10：00 虛擬at： www.virtualshareholdermeeting.com/PTPI2022 *Please查看會議材料以瞭解有關會議出席的任何特殊要求。 智能手機用户 將您的相機指向此處並進行投票，而無需輸入 控制編號 v1.1 以獲取完整信息並進行投票，訪問 www.ProxyVote.com Control# D91777-P81705 Petros PharmPharmticals，Inc. 美洲大道1185大道 紐約3樓 紐約郵編：10036 Petros PharmPharmticals，Inc.2022年年會投票截止時間：2022年11月28日 11：59 et 您投資了Petros PharmPharmticals，Inc. 現在是投票的時候了！ 您有權對在年會上提交的提案進行投票。 這是一份重要通知，涉及將於2022年11月29日舉行的股東大會的代理材料的可用性。 在投票前獲得通知 查看通知和委託書並在線填寫10-K表格，或者您可以在2022年11月15日之前提出請求的 收到材料的免費紙質或電子郵件副本。如果您希望索取本次和/或未來股東會議的材料副本，您可以(1)訪問www.ProxyVote.com，(2)致電1-800-579-1639或(3)發送電子郵件至sendMaterial@proxyvote.com。 如果發送電子郵件，請在主題行中包含您的控制編號(如下所示)。除非提出要求，否則您不會 收到紙質或電子郵件副本。

Vote at www.ProxyVote.com Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Sign up for E-delivery”. Voting Items Board Recommends D91778-P81705 THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. 1. To elect five directors to serve on our Board of Directors until the 2023 annual meeting of stockholders and until their respective successors are duly elected and qualified, or until their earlier death, resignation or removal. Nominees: 1b. Joshua N. Silverman 1c. Bruce T. Bernstein 1a. John D. Shulman 1d. Gregory Bradley 1e. Wayne R. Walker 2. To approve an amendment to our Amended and Restated Certificate of Incorporation to effect, at the discretion of the Board but prior to the one year anniversary of the date on which the reverse stock split is approved by the Company’s stockholders at the Annual Meeting, a reverse stock split of all of the outstanding shares of our Common Stock at a ratio in the range of 1-for-4 to 1-for-10, with such ratio to be determined by the Board in its discretion and included in a public announcement (the “Reverse Stock Split Proposal”). 3. To ratify the appointment of EisnerAmper LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022. 4. To approve, on an advisory basis, the compensation paid to the Company’s named executive officers. For For For For For For For For For 5. To approve a proposal to adjourn the Annual Meeting to a later date or dates, if necessary or appropriate, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of the Reverse Stock Split Proposal.